Denali Therapeutics (DNLI) Files Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts DNLI Hot Sheet
Join SI Premium – FREE
Denali Therapeutics (NASDAQ: DNLI) has filed mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Purchase Contracts
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Docusign brings agreement tools natively into Salesforce and Slack
- Micron Technology (MU) call put ratio 1.6 calls to 1 put as share price down 5.2%
- Paul Tudor Jones warns 2027 could be challenging for stocks
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
